All Stories

  1. Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study

    Article • Frontiers in Medicine, April 2017, Frontiers

    Grzegorz Bulaj

  2. Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2

    Article • Neurochemical Research, April 2017, Springer Science + Business Media

    Grzegorz Bulaj

  3. Music Streaming Services as Adjunct Therapies for Depression, Anxiety, and Bipolar Symptoms: Convergence of Digital Technologies, Mobile Apps, Emotions, and Global Mental Health

    Article • Frontiers in Public Health, September 2016, Frontiers

    Grzegorz Bulaj

  4. Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases

    Article • Current Clinical Pharmacology, August 2016, Bentham Science Publishers

    Grzegorz Bulaj

  5. Clinical and Neurobiological Perspectives of Empowering Pediatric Cancer Patients Using Videogames

    Article • Games for Health Journal, October 2015, Mary Ann Liebert Inc

    Grzegorz Bulaj

  6. A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties

    Article • Frontiers in Pharmacology, February 2015, Frontiers

    Grzegorz Bulaj

  7. Combining Non-Pharmacological Treatments with Pharmacotherapies for Neurological Disorders: A Unique Interface of the Brain, Drug–Device, and Intellectual Property

    Article • Frontiers in Neurology, July 2014, Frontiers

    Grzegorz Bulaj

  8. Incorporation of Monodisperse Oligoethyleneglycol Amino Acids into Anticonvulsant Analogues of Galanin and Neuropeptide Y Provides Peripherally Acting Analgesics

    Article • Molecular Pharmaceutics, February 2013, American Chemical Society (ACS)

    Grzegorz Bulaj

  9. Reagentless Oxidative Folding of Disulfide-Rich Peptides Catalyzed by an Intramolecular Diselenide

    Article • Angewandte Chemie, March 2012, Wiley

    Grzegorz Bulaj

  10. Anticonvulsant neuropeptides as drug leads for neurological diseases

    Article • Natural Product Reports, January 2011, Royal Society of Chemistry

    Grzegorz Bulaj

  11. Engineering Galanin Analogues That Discriminate between GalR1 and GalR2 Receptor Subtypes and Exhibit Anticonvulsant Activity following Systemic Delivery

    Article • Journal of Medicinal Chemistry, February 2010, American Chemical Society (ACS)

    Grzegorz Bulaj

  12. Developing novel antiepileptic drugs: Characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models

    Article • Neurotherapeutics, April 2009, Springer Science + Business Media

    Grzegorz Bulaj

  13. Conotoxins Containing Nonnatural Backbone Spacers: Cladistic-Based Design, Chemical Synthesis, and Improved Analgesic Activity

    Article • Chemistry & Biology, April 2007, Elsevier

    Grzegorz Bulaj